{"nct_id":"NCT03078751","title":"Adjuvant Ribociclib With Endocrine Therapy in Hormone Receptor+/HER2- High Risk Early Breast Cancer","status":"COMPLETED","status_verified_date":"2021-10","start_date":"2017-06-20","start_date_type":"ACTUAL","primary_completion_date":"2020-03-09","primary_completion_date_type":"ACTUAL","completion_date":"2020-03-09","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["NVS"]}